Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ PEth 16:0/18:1-D5 Solution, 100 μg/mL in Methanol (as free phosphate), Sold by MilliporeSigma™ Supelco™

Certified reference material

Supplier:  MilliporeSigma Supelco P1511ML

Catalog No. 01-001-902


Due to product restrictions, please to purchase or view availability for this product.


Description

Description

This stable-labeled internal standard is suitable for quantitation of PEth 16:0/18:1 in LC/MS or GC/MS applications. PEth 16:0/18:1, also known as phosphatidylethanol 16:0/18:1, is a sensitive and specific biomarker for alcohol use and abuse. Since the detection window of PEth 16:0/18:1 in blood is longer than that of ethyl glucuronide (EtG) or ethyl sulfate (EtS) in urine, measurement of blood PEth 16:0/18:1 level is routinely performed in clinical toxicology and forensic testing applications such as abstinence monitoring and workplace drug testing. PEth 16:0/18:1 has also been investigated as a biomarker to confirm prenatal alcohol exposure (PAE).
Specifications

Specifications

67-56-1
100 μg/mL in methanol (as free phosphate)
Ampule
C39H69D5O8P · NC3H10
767.12
1 mL
Product Suggestions

Product Suggestions

Safety and Handling

Safety and Handling

Recommended Storage : -70°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

CERILLIANT is a registered trademark of Cerilliant Corporation